PEP-010 is under clinical development by PEP-Therapy and currently in Phase I for Metastatic Ovarian Cancer. According to GlobalData, Phase I drugs for Metastatic Ovarian Cancer have a 77% phase ...

PEP-010 is under clinical development by PEP-Therapy and currently in Phase I for Pancreatic Ductal Adenocarcinoma. According to GlobalData, Phase I drugs for Pancreatic Ductal Adenocarcinoma does not ...

It also holds your airways open, keeping them from closing. Although your respiratory therapist may suggest a different way to use PEP based on your unique circumstances, typically, people perform 10 ...

For example, combining a PEP device with nebulized medications means medication is inhaled on each inspiration while sputum clearance is promoted on each expiration. Reducing therapy time can be ...